Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Grotta

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
International Journal of Stroke : Official Journal of the International Stroke Society|August 24, 2021
Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trialAndrew M Naidech, James Grotta, Jordan Elm, et al.
Neurocritical Care|July 31, 2024
Serial Diffusion Tensor Imaging and Rate of Ventricular Blood Clearance in Patients with Intraventricular HemorrhageVedang Vyas, Sean I Savitz, Seth B Boren, et al.
The Lancet. Neurology|May 5, 2015
Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trialGregory W Albers, Rüdiger von Kummer, Thomas Truelsen, et al.
Stroke|February 28, 2020
Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over PlaceboShashank Agarwal, Erica Scher, Aaron Lord, et al.
JAMA Neurology|October 28, 2024
Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous ThrombolysisBrian Mac Grory, Jie-Lena Sun, Brooke Alhanti, et al.
Stroke|November 3, 2016
Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke)Rüdiger von Kummer, Etsuro Mori, Thomas Truelsen, et al.
JAMA Neurology|July 30, 2019
Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) StudyAmrou Sarraj, Ameer E Hassan, Sean Savitz, et al.
Stroke|December 7, 2020
Early Infarct Growth Rate Correlation With Endovascular Thrombectomy Clinical Outcomes: Analysis From the SELECT StudyAmrou Sarraj, Ameer E Hassan, James Grotta, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Neurology Trainee Attitudes Toward Neurointervention: Results From an International SurveySaurav Das, Maxim Mokin, Sunil A Sheth, et al.
Stroke|October 27, 2023
Most Promising Approaches to Improve Stroke Outcomes: The Stroke Treatment Academic Industry Roundtable XII WorkshopLawrence R Wechsler, Opeolu Adeoye, Fana Alemseged, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
International Journal of Stroke : Official Journal of the International Stroke Society|August 24, 2021
Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trialAndrew M Naidech, James Grotta, Jordan Elm, et al.
Neurocritical Care|July 31, 2024
Serial Diffusion Tensor Imaging and Rate of Ventricular Blood Clearance in Patients with Intraventricular HemorrhageVedang Vyas, Sean I Savitz, Seth B Boren, et al.
The Lancet. Neurology|May 5, 2015
Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trialGregory W Albers, Rüdiger von Kummer, Thomas Truelsen, et al.
Stroke|February 28, 2020
Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over PlaceboShashank Agarwal, Erica Scher, Aaron Lord, et al.
JAMA Neurology|October 28, 2024
Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous ThrombolysisBrian Mac Grory, Jie-Lena Sun, Brooke Alhanti, et al.
Stroke|November 3, 2016
Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke)Rüdiger von Kummer, Etsuro Mori, Thomas Truelsen, et al.
JAMA Neurology|July 30, 2019
Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) StudyAmrou Sarraj, Ameer E Hassan, Sean Savitz, et al.
Stroke|December 7, 2020
Early Infarct Growth Rate Correlation With Endovascular Thrombectomy Clinical Outcomes: Analysis From the SELECT StudyAmrou Sarraj, Ameer E Hassan, James Grotta, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Neurology Trainee Attitudes Toward Neurointervention: Results From an International SurveySaurav Das, Maxim Mokin, Sunil A Sheth, et al.
Stroke|October 27, 2023
Most Promising Approaches to Improve Stroke Outcomes: The Stroke Treatment Academic Industry Roundtable XII WorkshopLawrence R Wechsler, Opeolu Adeoye, Fana Alemseged, et al.
Pageof 5